Value of allogeneic versus autologous stem cell transplantation and chemotherapy in patients with myelodysplastic syndromes and secondary acute myeloid leukemia. Final results of a prospective randomized European Intergroup Trial-Reference-Cited by-同舟云学术

Value of allogeneic versus autologous stem cell transplantation and chemotherapy in patients with myelodysplastic syndromes and secondary acute myeloid leukemia. Final results of a prospective randomized European Intergroup Trial

Published:2010-05-21 Issue:10 Volume:95 Page:1754-1761
ISSN:0390-6078
Container-title:Haematologica
language:en
Short-container-title:Haematologica

Author:

de Witte T.,Hagemeijer A.,Suciu S.,Belhabri A.,Delforge M.,Kobbe G.,Selleslag D.,Schouten H. C.,Ferrant A.,Biersack H.,Amadori S.,Muus P.,Jansen J. H.,Hellstrom-Lindberg E.,Kovacsovics T.,Wijermans P.,Ossenkoppele G.,Gratwohl A.,Marie J.-P.,Willemze R.

Publisher

Ferrata Storti Foundation (Haematologica)

Subject

Hematology

Cited by 69 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of atrial fibrillation prevalence and in-hospital cardiovascular outcomes between patients undergoing allogeneic versus autologous hematopoietic stem cell transplantation: insights from the national inpatient sample;Scientific Reports;2024-07-22

2. Treatment strategy at the decision for allogeneic transplantation in patients with myelodysplastic syndrome in the era of azacitidine: A KSGCT prospective study;Leukemia Research;2023-10

3. Phase 2 study of PD-1 blockade following autologous transplantation for patients with AML ineligible for allogeneic transplant;Blood Advances;2023-09-13

4. Hematopoietic Stem Cell Transplantation for Myelodysplastic Syndromes;The Cancer Journal;2023-05

5. Stem Cell Transplant for Acute Myeloid Leukemia;Basics of Hematopoietic Stem Cell Transplant;2023